How many employees work at AfroCentric Investment?

About AfroCentric Investment

AfroCentric Investment Corporation Limited is a black-owned, investment holding company which is substantially invested in healthcare. Through our operating subsidiaries, we provide health administration and health risk management solutions to the healthcare funding industry. In addition, AfroCentric provides a range of complementary services to its traditional medical scheme clients as well as a portfolio of healthcare-related enterprises. These services include IT solutions, transactional switching and specialised disease management. Medscheme is the Group’s largest subsidiary and is one of South Africa’s largest medical scheme administrators and managed care providers. Founded over four decades ago, Medscheme has more than 3.2 million lives under management through its 15 client medical schemes in South Africa. It is the largest black-owned medical scheme administrator, with a national footprint of 16 offices in all the major centres in South Africa, employing over 3 000 staff. In addition Medscheme has a presence in Botswana, Namibia, Swaziland, Kenya and Zimbabwe, and through its business process outsourcing centre in Mauritius provides services to several large European and UK-based health insurance companies. More recently, AfroCentric acquired a 100% interest in Pharmacy Direct, a courier pharmacy; 100% of Curasana, a pharmaceutical wholesaler; and a 26% stake in Activo Health, a southern African distributor of generic medicines as well as complementary nutraceutical products effective 1 August 2015. These acquisitions should not only improve the Group’s earnings, but will provide greater access to the wider healthcare delivery value chain and greater visibility in the relevant markets. We were founded on the core philosophy of transformation and empowerment, and is one of very few black-owned and controlled companies on the JSE. As a level 2 B-BBEE-rated company it is also the most empowered health related business on the JSE.